Key statistics
As of last trade, Actinium Pharmaceuticals Inc (7AY1:FRA) traded at 0.969, 12.67% above the 52 week low of 0.86 set on Feb 19, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 0.969 |
|---|---|
| High | 0.969 |
| Low | 0.969 |
| Bid | 0.9585 |
| Offer | 0.9925 |
| Previous close | 0.945 |
| Average volume | 28.57 |
|---|---|
| Shares outstanding | 31.20m |
| Free float | 30.46m |
| P/E (TTM) | -- |
| Market cap | 36.81m USD |
| EPS (TTM) | -1.11 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 07:09 GMT.
More ▼
Press releases
- Actinium Pharmaceuticals, Inc. to Present Two Abstracts at the 2026 AACR Annual Meeting
- Actinium Pharmaceuticals Presents New Preclinical Data Demonstrating Potent Anti-Tumor Activity of ATNM-400 Across Multiple Breast Cancer Subtypes Including Hormone Receptor-Positive, Triple-Negative, and Tamoxifen- and HER2 Therapy-Resistant Breast Cancer Models at SABCS 2025
